(QLTY) The 2023 Series Trust II - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US90139K1007

QLTY: Common Stocks, Preferred Stocks, Convertible Securities, Depositary Receipts, Equity REITs, Income Trusts, Other Equity Investment Companies

The2023 ETF Series Trust II (NASDAQ:QLTY) is an actively managed exchange-traded fund that focuses on investing in high-quality U.S. equities. The funds adviser, Grantham, Mayo, Van Otterloo & Co. LLC (GMO), employs a rigorous selection process to identify top-tier companies. The investment portfolio comprises a diverse range of equity securities, including common and preferred stocks, as well as other stock-related instruments such as convertible securities and equity real estate investment trusts.

As a Large Blend ETF, QLTY is designed to provide broad exposure to the U.S. equity market, with a focus on high-quality companies. The funds assets under management (AUM) stand at approximately $1.863 billion, indicating a significant presence in the market. GMOs investment strategy is centered around identifying companies with strong fundamentals, which are expected to drive long-term growth and stability.

Analyzing the technical data, we observe that QLTYs last price is $33.17, with a 20-day simple moving average (SMA) of $32.67, indicating a positive trend. The 50-day SMA and 200-day SMA are $31.38 and $32.10, respectively, further supporting the bullish sentiment. The average true range (ATR) is 1.15%, suggesting moderate volatility. Given these technical indicators, we forecast that QLTY will continue to trend upwards, potentially reaching $35.00 in the near term, driven by the ongoing bullish momentum.

Combining the fundamental and technical analysis, we expect QLTY to maintain its upward trajectory, driven by GMOs expertise in identifying high-quality companies and the overall positive market sentiment. As the fund continues to attract assets, its AUM is likely to grow, further solidifying its position in the market. Our forecast suggests that QLTY will remain a strong contender in the Large Blend ETF category, with potential for long-term growth and stability.

Additional Sources for QLTY ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

QLTY ETF Overview

Market Cap in USD 1,863m
Category Large Blend
TER 0.50%
IPO / Inception 2023-11-13

QLTY ETF Ratings

Growth Rating 46.8
Fundamental -
Dividend Rating 40.1
Rel. Strength -1.97
Analysts -
Fair Price Momentum 31.13 USD
Fair Price DCF -

QLTY Dividends

Dividend Yield 12m 0.78%
Yield on Cost 5y 1.02%
Annual Growth 5y 148.41%
Payout Consistency 66.7%
Payout Ratio %

QLTY Growth Ratios

Growth Correlation 3m 66.3%
Growth Correlation 12m 32.7%
Growth Correlation 5y 80.5%
CAGR 5y 19.81%
CAGR/Max DD 5y 1.17
Sharpe Ratio 12m 1.04
Alpha -1.55
Beta 0.878
Volatility 10.46%
Current Volume 160.6k
Average Volume 20d 137.7k
What is the price of QLTY shares?
As of June 15, 2025, the stock is trading at USD 33.17 with a total of 160,571 shares traded.
Over the past week, the price has changed by +0.61%, over one month by +2.41%, over three months by +7.13% and over the past year by +9.02%.
Is The 2023 Series Trust II a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, The 2023 Series Trust II (NASDAQ:QLTY) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 46.77 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of QLTY is around 31.13 USD . This means that QLTY is currently overvalued and has a potential downside of -6.15%.
Is QLTY a buy, sell or hold?
The 2023 Series Trust II has no consensus analysts rating.
What are the forecasts for QLTY share price target?
According to our own proprietary Forecast Model, QLTY The 2023 Series Trust II will be worth about 35.3 in June 2026. The stock is currently trading at 33.17. This means that the stock has a potential upside of +6.51%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 35.3 6.5%